Medical Professional financing for your medical practice! Learn how to get funding with medical practice financing. More Info Here!
Call: 904-551-6090
Over the years we have been able to finance a lot of start up medical practice units with excellent services. The great repayments rates that are stated by the company will give you the chance to order your finances well. All the low repayment rates are aimed at financing your financial program by virtue that it was specifically designed to help fresh medical doctors who are in need of financial assistance to start up their medical practice. With confidence, you should make our company your financial source as we are dedicated to make your dreams a reality.
Read The Interesting Snippets Below For Exciting Health-Care News!
UPDATE 1-WHO sees small-scale use of experimental Ebola vaccines in January
– http://www.reuters.com
* WHO focused on candidate GSK, Newlink shots if shown safe
DAKAR (Reuters) – The death toll from an outbreak of Ebola in West Africa has risen to at least 3,091 out of 6,574 probable, suspected and confirmed cases, the World Health Organization said on Friday.
WHO sees small-scale use of experimental Ebola vaccines in January
– http://www.reuters.com/healthNews
GENEVA (Reuters) – The World Health Organisation (WHO) said on Friday it expected to begin small-scale use of two experimental Ebola vaccines in West Africa early next year and in the meantime transfusions of survivors’ blood may offer the best hope of treatment.
WASHINGTON, Sept 26 (Reuters) – The asthma drug Xolair is associated with a higher risk of heart attack, mini-stroke, chest pain and blood clots in the lungs and veins, among other problems, though the extent of increased risk is unclear, the U.S. Food and Drug Administration said on Friday.
SHANGHAI (Reuters) – China has vowed to hand out the “harshest penalties” to food safety violators and to further reform the food and drug safety administration, Xinhua news agency said on Saturday.
Sept 26 (Reuters) – The U.S. Food and Drug Administration has granted a six-month, priority review to Bristol-Myers Squibb Co’s application for immuno-oncology drug Opdivo as a treatment for previously treated melanoma, the company said on Friday.
Dental Practice Financing!
No down payment medical, dental and healthcare provider practice financing here! + More News: Bristol immunotherapy gets 6-month U.S. FDA review for melanoma + MORE 09/27/2014
No comments:
Post a Comment